Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx

Background<p>Lung adenocarcinoma (LUAD) is a leading cause of cancer-related mortality. Protein succinylation, a key post-translational modification, is implicated in tumor progression. However, its comprehensive landscape and clinical significance in LUAD remain largely unexplored.</p>M...

保存先:

書誌詳細
第一著者:	Jichang Liu (1263291) (author)
その他の著者:	Xuehan Zhu (11957429) (author), Chenlong Zha (22687058) (author), Jiaqi Ding (8599578) (author), Chuanpeng Zhang (11677948) (author), Yizhe Wang (2287393) (author), Tao Yan (429415) (author), Hui Kong (4516105) (author), Yong Liu (6908) (author), Jingyu Chen (3571688) (author)
出版事項:	2025
主題:	Genetic Immunology succinylation lung adenocarcinoma KLK6 prognosis immunotherapy
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
著者:: Jichang Liu (1263291)
出版事項: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
著者:: Jichang Liu (1263291)
出版事項: (2025)

Image 1_Investigating the prognostic significance of examined lymph node count in elderly women with cervical carcinoma: a SEER population-based study.tif
著者:: Weilan Liu (12963164)
出版事項: (2025)

Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 5_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Image 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
著者:: Xiangjun Wang (2522917)
出版事項: (2025)

Diagnostic and prognostic value of inflammatory markers for patients with severe pneumonia: a meta-analysis
著者:: Meng Han (782687)
出版事項: (2025)

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx
著者:: Yanju Li (9697993)
出版事項: (2025)

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
著者:: Rui Wang (52434)
出版事項: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
著者:: Rui Wang (52434)
出版事項: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
著者:: Rui Wang (52434)
出版事項: (2025)

Table 1_Low-dose statins combined with repetitive transcranial magnetic stimulation reduce post-stroke depression.docx
著者:: Chaohua Cui (1793155)
出版事項: (2025)

Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients
著者:: Kaixiang He (13263834)
出版事項: (2025)

Development of [89Zr]Zr-DFO-hu3F8 and [225Ac]Ac-DOTA-hu3F8 Theranostic Pairs Targeting GD2 in Neuroblastomas
著者:: Lingling Zheng (1628176)
出版事項: (2025)

Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
著者:: Alexander N. Shoushtari (15023909)
出版事項: (2025)

Industry-level heterogeneity analysis.
著者:: Yuanbo Hu (10142927)
出版事項: (2025)

Firm-level heterogeneity analysis.
著者:: Yuanbo Hu (10142927)
出版事項: (2025)

Definitions for heterogeneity analysis groupings.
著者:: Yuanbo Hu (10142927)
出版事項: (2025)

Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
著者:: Dongliang Leng (17079663)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_8p7gbqjn3mlb9a5sqjdq2sfcru